GAD1

Chr 2

glutamate decarboxylase 1

Also known as: CPSQ1, DEE89, GAD, GAD-67, SCP

This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.47
Clinical SummaryGAD1
🧬
Gene-Disease Validity (ClinGen)
obsolete early infantile epileptic encephalopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.27) despite low pLI — interpret in context.
📋
ClinVar Variants
18 unique Pathogenic / Likely Pathogenic· 130 VUS of 309 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.47LOEUF
pLI 0.046
Z-score 3.89
OE 0.27 (0.160.47)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.32Z-score
OE missense 0.64 (0.580.72)
217 obs / 336.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.27 (0.160.47)
00.351.4
Missense OE?0.64 (0.580.72)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 9 / 33.1Missense obs/exp: 217 / 336.5Syn Z: 0.29
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedGAD1-related cerebral palsy spastic quadriplegicOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6937th %ile
GOF
0.6443th %ile
LOF
0.3744th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

309 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic8
VUS130
Likely Benign108
Benign32
Conflicting14
10
Pathogenic
8
Likely Pathogenic
130
VUS
108
Likely Benign
32
Benign
14
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
2
0
0
10
Likely Pathogenic
6
2
0
0
8
VUS
1
94
31
4
130
Likely Benign
0
3
46
59
108
Benign
0
1
29
2
32
Conflicting
14
Total1510210665302

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

20 pathogenic / likely-pathogenic (of 22) ClinVar copy-number / structural variants overlap GAD1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GAD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →